Toggle light / dark theme

In the early days of the space race of the 1960s, NASA used satellites to map the geography of the moon. A better understanding of its geology, however, came when men actually walked on the moon, culminating with Astronaut and Geologist Harrison Schmitt exploring the moon’s surface during the Apollo 17 mission in 1972.

Image credit: Scientific American
Image credit: Scientific American

In the modern era, Dr. Gregory Hickock is one neuroscientist who believes the field of neuroscience is pursuing comparable advances. While scientists have historically developed a geographic map of the brain’s functional systems, Hickock says computational neuroanatomy is digging deeper into the geology of the brain to help provide an understanding of how the different regions interact computationally to give rise to complex behaviors.

“Computational neuroanatomy is kind of working towards that level of description from the brain map perspective. The typical function maps you see in textbooks are cartoon-like. We’re trying to take those mountain areas and, instead of relating them to labels for functions like language, we’re trying to map them on — and relate them to — stuff that the computational neuroscientists are doing.”

Hickok pointed to a number of advances that have already been made through computational neuroanatomy: mapping visual systems to determine how the visual cortex can code information and perform computations, as well as mapping neurally realistic approximations of circuits that actually mimic motor control, among others. In addition, researchers are building spiking network models, which simulate individual neurons. Scientists use thousands of these neurons in simulations to operate robots in a manner comparable to how the brain might perform the job.

That research is driving more innovation in artificial intelligence, says Gregory. For example, brain-inspired models are being used to develop better AI systems for stores of information or retrieval of information, as well as in automated speech recognition systems. In addition, this sort of work can be used to develop better cochlear implants or other sorts of neural-prostheses, which are just starting to be explored.

“In terms of neural-prostheses that can take advantage of this stuff, if you look at patterns and activity in neurons or regions in cortex, you can decode information from those patterns of activity, (such as) motor plans or acoustic representation,” Hickok said. “So it’s possible now to implant an electrode array in the motor cortex of an individual who is locked in, so to speak, and they can control a robotic arm.”

More specifically, Hickok is interested in applying computational neuroanatomy to speech and language functions. In some cases where patients have lost the ability to produce fluid speech, he states that the cause is the disconnection of still-intact brain areas that are no longer “talking to each other”. Once we understand how these circuits are organized and what they’re doing computationally, Gregory believes we might one day be able to insert electrode arrays and reconnect those brain areas as a form of rehabilitation.

As he looks at the future applications in artificial intelligence, Hickok says he expects continued development in neural-prostheses, such as cochlear implants, artificial retinas, and artificial motor control circuits. The fact that scientists are still trying to simulate how the brain does its computations is one hurdle; the “squishy” nature of brain matter seems to operate differently than the precision developed in digital computers.

Though multiple global brain projects are underway and progress is being made (Wired’s Katie Palmer gives a succinct overview), Gregory emphasizes that we’re still nowhere close to actually re-creating the human mind. “Presumably, this is what evolution has done over millions of years to configure systems that allow us to do lots of different things and that is going to (sic) take a really long time to figure out,” he said. “The number of neurons involved, 80 billion in the current estimate, trillions of connections, lots and lots of moving parts, different strategies for coding different kinds of computations… it’s just ridiculously complex and I don’t see that as something that’s easily going to give up its secrets within the next couple of generations.”

CRISPR, CRISPR, CRISPR. We’ve all heard about it’s gene editing capability, but it has potential to do so much more — controlling genes and offering a precise delivery system.

More than an editing platform

The CRISPR-Cas9 system does a wonderful job, partly because it targets genes so specifically. It’s not the only system that does this, but it’s the cheapest and easiest to create so far. For those with imagination however, this targeting quality means it could do so much more than simply snip away at sequences. Targeting promoter sequences, delivering a payload to a specific region of DNA…the platform has enormous potential.

Read more

ProfusaLast week at CES, South San Francisco based Profusa showed off an upcoming injectable sensor that can be used to continuously monitor oxygen levels in tissue. Measuring only five millimeters long and a tiny 250 microns in diameter, the biosensor can be injected into tissue with just a hypodermic needle. It consists of a soft hydrogel scaffold that allows it to be biologically compatible with the surrounding tissue without any foreign body response. The sensor also contains a special chemical marker that changes fluorescence depending on the amount of oxygen that reacts with it. An optical reader placed on the skin measures the fluorescence and relays the data to a smartphone. The biosensor can last as long as two years (at which point the chemical marker begins to lose its potency), and because it contains no electronics and is completely biocompatible there’s no need to remove it.

On stage at the CES Digital Health Summit, Profusa CEO Dr. Ben Hwang gave a live demonstration of how the sensor works in action. As two of his colleagues with the sensors implanted and using a blood pressure cuffs performed stretches to simulate changes in blood flow, a graph displayed the live view of the changing tissue oxygen levels at the site of the sensors.

We had the opportunity to talk to Dr. Hwang after his talk, and he shared that the first application of the sensor is the Lumee Oxygen Sensing System, which is designed to monitor oxygen levels during the wound healing process. Sufficient oxygen flow through a wound is vital to the healing process, and Lumee can detect low oxygen levels early in the healing process and even before treatment or surgery begins.

Read more

Anyone offended by the prospect of drinking fine whiskey inside sealed space packs with straws after Suntory sent its finest variety to the ISS for testing? Don’t worry: Ballantine’s got your back. The liquor company has commissioned Open Space Agency’s James Parr — who also created a Lumia-powered 3D-printed telescope in the past — to design a high-tech whiskey glass especially for zero-G environments. He tested a number of designs before settling on a rounded glass with a spiral convex stainless steel base plated in rose gold that can create the surface tension necessary to hold the liquor down. The liquid then passes through channels on the sides of the glass all the way up to the golden mouthpiece.

The “glass” part itself is actually 3D-printed medical-grade PLA plastic, the same kind used for heart valves. Since everything tends to float in microgravity, the base hides a 22-pound magnet that can be used to stick the glass on magnetic surfaces. Plus, it has a one way valve where a customized whiskey bottle nozzle can be inserted to pour out a shot. Parr and Ballantine published more details about the design process on Medium, if you’d like to read more about how the “space glass” was created. Sure, it could be nothing but a marketing stunt, but it’s amazing how much thought went into designing a whiskey glass. It’s unfortunate that most of us might never get to use it in its intended environment; good thing the final product at least looks fancy enough to display.

Read more

Early detection by Grail (leveraging illumina’s gene sequencing technology) looks promising. This truly will be beneficial for early detection. And, I will be very interested in seeing how it benefits those who are genetically pre-disposed to cancer related gene mutations especially around Esaphogus, Glioblastoma, and Pancreatic cancers since these are often hard to detect in their earliest stages.

Read more

A nice telomerase overview. I’m spoiling the end: “I think it’d be great if the cure for aging came out of the land of the hobbits.”


Dr. Bill Andrews is the creator of TAM-818, the world’s most powerful anti-aging active ingredient. TAM-818 is only found in One Truth 818 serum. For more information or to purchase visit http://www.tam818.com/

William Henry “Bill” Andrews, Ph.D. is an American molecular biologist and gerontologist whose career has centered on searching for a cure for human aging. Andrews is the founder and president of the biotechnology company Sierra Sciences. In 1997, he led the team at Geron Corporation that was the first to successfully identify human telomerase.